Literature DB >> 6717508

Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer.

K M Taylor, R G Margolese, C L Soskolne.   

Abstract

We studied the reasons surgical principal investigators chose not to enter patients in a large, multicenter trial sponsored by a cooperative group. In 1976 the National Surgical Adjuvant Project for Breast and Bowel Cancers (NSABP) initiated a clinical trial to compare segmental mastectomy and postoperative radiation, or segmental mastectomy alone, with total mastectomy. Because the low rates of accrual were threatening to close the trial prematurely, we mailed a questionnaire to the 94 NSABP principal investigators, asking why they were not entering eligible patients in the trial. A response rate of 97 per cent was achieved. Physicians who did not enter all eligible patients offered the following explanations: (1) concern that the doctor-patient relationship would be affected by a randomized clinical trial (73 per cent), (2) difficulty with informed consent (38 per cent), (3) dislike of open discussions involving uncertainty (22 per cent), (4) perceived conflict between the roles of scientist and clinician (18 per cent), (5) practical difficulties in following procedures (9 per cent), and (6) feelings of personal responsibility if the treatments were found to be unequal (8 per cent). Further investigation into the behavioral aspects of the investigator-patient relationship is particularly pressing, since fear of change in this relationship was the most common reason given for not entering eligible patients in the trial.

Entities:  

Mesh:

Year:  1984        PMID: 6717508     DOI: 10.1056/NEJM198405243102106

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  77 in total

Review 1.  Increasing participation of minorities in cancer clinical trials: summary of the "Moving Beyond the Barriers" Conference in North Carolina.

Authors:  Nancy Stark; Electra Paskett; Ronny Bell; M Robert Cooper; Elizabeth Walker; Alma Wilson; Cathy Tatum
Journal:  J Natl Med Assoc       Date:  2002-01       Impact factor: 1.798

2.  For and against: clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial.

Authors:  C Weijer; S H Shapiro; K Cranley Glass
Journal:  BMJ       Date:  2000-09-23

3.  Investigator barriers and preferences to conduct clinical drug trials in Finland: a qualitative study.

Authors:  Tuija Keinonen; Tapani Keränen; Timo Klaukka; Veijof Saano; Pauli Ylitalo; Hannes Enlund
Journal:  Pharm World Sci       Date:  2003-12

4.  Tribulations for clinical trials.

Authors:  I M Macintyre
Journal:  BMJ       Date:  1991-05-11

5.  A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).

Authors:  Sara H Javid; Joseph M Unger; Julie R Gralow; Carol M Moinpour; Antoinette J Wozniak; J Wendall Goodwin; Primo N Lara; Pamela A Williams; Laura F Hutchins; Carolyn C Gotay; Kathy S Albain
Journal:  Oncologist       Date:  2012-06-20

6.  Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis.

Authors:  D Cook; Y Arabi; N Ferguson; D Heels-Ansdell; A Freitag; E McDonald; F Clarke; S Keenan; G Pagliarello; W Plaxton; M Herridge; T Karachi; S Vallance; J Cade; T Crozier; S Alves da Silva; R Costa Filho; N Brandao; I Watpool; T McArdle; G Hollinger; Y Mandourah; M Al-Hazmi; N Zytaruk; N K J Adhikari
Journal:  Intensive Care Med       Date:  2013-12       Impact factor: 17.440

7.  The Study Centre of the German Surgical Society--rationale and current status.

Authors:  Hanns-Peter Knaebel; Markus K Diener; Moritz N Wente; Hartwig Bauer; Markus W Büchler; Matthias Rothmund; Christoph M Seiler
Journal:  Langenbecks Arch Surg       Date:  2005-02-22       Impact factor: 3.445

8.  Development of an electronic health record-based Clinical Trial Alert system to enhance recruitment at the point of care.

Authors:  Peter J Embi; Anil Jain; Jeffrey Clark; C Martin Harris
Journal:  AMIA Annu Symp Proc       Date:  2005

9.  Sick population--treated population: the need for a better definition. The VALIDATA Group.

Authors:  J P Collet; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  Physicians' preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs.

Authors:  Scott D Halpern; Peter A Ubel; Jesse A Berlin; Raymond R Townsend; David A Asch
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.